All Stories

  1. IGF-1 assessed by pubertal status has the best positive predictive power for GH deficiency diagnosis in peripubertal children
  2. IHH gene mutations causing short stature with non-specific skeletal abnormalities and response to growth hormone therapy
  3. MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature
  4. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2
  5. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations
  6. STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritability
  7. Autosomal recessive form of isolated growth hormone deficiency is more frequent than the autosomal dominant form in a Brazilian cohort
  8. Genetic Predictors of Long-Term Response to Growth Hormone (GH) Therapy in Children With GH Deficiency and Turner Syndrome: The Influence of a SOCS2 Polymorphism
  9. Genome-wide screening of copy number variants in children born small for gestational age reveals several candidate genes involved in growth pathways
  10. The E180splice mutation in theGHRgene causing Laron syndrome: Witness of a Sephardic Jewish exodus from the Iberian Peninsula to the New World?
  11. Developmental Syndromes of Ras/MAPK Pathway Dysregulation
  12. Role of the Natriuretic Peptide System in Normal Growth and Growth Disorders
  13. Heterozygous Mutations in Natriuretic Peptide Receptor-B (NPR2) Gene as a Cause of Short Stature in Patients Initially Classified as Idiopathic Short Stature
  14. Genetics of SHOX Deficiency
  15. The Interactive Effect ofGHR-Exon 3and −202 A/C IGFBP3Polymorphisms on rhGH Responsiveness and Treatment Outcomes in Patients with Turner Syndrome
  16. Post-receptor IGF1 insensitivity restricted to the MAPK pathway in a Silver-Russell syndrome patient with hypomethylation at the imprinting control region on chromosome 11
  17. Mutações no gene do receptor do fator de crescimento insulina-símile 1 (IGF1R) como causa de retardo do crescimento pré- e pós-natal
  18. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant
  19. Investigação de baixa estatura: aspectos clínicos, laboratoriais e moleculares da insensibilidade ao hormônio de crescimento
  20. Tratamento com hormônio de crescimento: aspectos moleculares, clínicos e terapêuticos
  21. Diagnosis and Long-Term Human Growth Hormone Treatment of a Boy with Noonan Syndrome
  22. Growth Hormone (GH) Pharmacogenetics: Influence of GH Receptor Exon 3 Retention or Deletion on First-Year Growth Response and Final Height in Patients with Severe GH Deficiency
  23. PTPN11(Protein Tyrosine Phosphatase, Nonreceptor Type 11) Mutations and Response to Growth Hormone Therapy in Children with Noonan Syndrome
  24. Acromegalic features in growth hormore (GH)‐deficient patients after long‐term GH therapy